Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
When AOD 9604 binds to fat cells, it upregulates lipolysis, the process of breaking stored triglycerides into free fatty acids and glycerol that the body can then use for energy
Early haematological response begins with reticulocytosis (increased production of immature red blood cells) typically by day 3-4 of treatment , particularly with injectable forms, though the full resolution of symptoms may take several weeks to months
Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome
Peptides Studied in Cellular Aging Models Cellular aging research centers on pathways like telomere maintenance, oxidative stress response, and mitochondrial efficiency
